Anne Wang, Athena Adeli, David Kylhammar, Eva Swahn, Jan E Engvall, Lars Lind, Stefan Söderberg, Anders Blomberg, Gunnar Engström, Jonas Spaak, Henrik Löfmark, Carl Johan Östgren, Tomas Jernberg, Göran Bergström, Magnus Settergren, Bahira Shahim
{"title":"Prevalence and Common Cardiovascular Risk Factors in Aortic Valve Calcification in the Middle-aged General Population.","authors":"Anne Wang, Athena Adeli, David Kylhammar, Eva Swahn, Jan E Engvall, Lars Lind, Stefan Söderberg, Anders Blomberg, Gunnar Engström, Jonas Spaak, Henrik Löfmark, Carl Johan Östgren, Tomas Jernberg, Göran Bergström, Magnus Settergren, Bahira Shahim","doi":"10.1093/eurjpc/zwaf157","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Aortic valve calcification (AVC) is an underlying pathophysiological mechanism for aortic stenosis which is common in the elderly, but less is known in younger individuals. The aim was to study the prevalence and associated characteristics of AVC in a middle-aged general population.</p><p><strong>Methods: </strong>Data were obtained from the Swedish CArdioPulmonary bioImage Study (SCAPIS) comprising 30,154 individuals 50 to 64 years from the general population recruited in Sweden between 2013-2018. AVC was assessed visually on computed tomography (CT) and categorized as evident or not. Population attributable risk proportion (PARP) was calculated for six modifiable risk factors (smoking, hypertension, hyperlipidemia, diabetes, BMI ≥median and kidney dysfunction [eGFR <60 ml/min/1.73 m2]).</p><p><strong>Results: </strong>In total, 29,221 individuals with CT images available were included (mean age 57.5 years, 51% female) and AVC was present in 2,053 (7%). The AVC prevalence increased with age (50-54 years: 3%; 55-59 years: 7%; 60-64 years: 11%). In analyses adjusted for age, sex, smoking and study site, male sex (OR 2.02, 95% CI 1.84-2.22), hyperlipidemia (1.88 [1.68-2.11]), hypertension (1.73 [1.57-1.91]), diabetes (1.66 [1.39-1.97]), kidney dysfunction (1.54 [1.10-2.11]), smoking (1.36 [1.24-1.50]), age (increment by one year) (1.12 [1.11-1.13]) and BMI (increment by one unit) (1.04 [1.03-1.05) were associated with AVC. The PARP of AVC associated with the six modifiable risk factors was 34.5% (95% CI 29.6-39.4).</p><p><strong>Conclusions: </strong>In this large, contemporary middle-aged general population, AVC was prevalent in as many as 7% and six cardiovascular risk factors contributed to one third of the prevalence of AVC.</p>","PeriodicalId":12051,"journal":{"name":"European journal of preventive cardiology","volume":" ","pages":""},"PeriodicalIF":8.4000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of preventive cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurjpc/zwaf157","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: Aortic valve calcification (AVC) is an underlying pathophysiological mechanism for aortic stenosis which is common in the elderly, but less is known in younger individuals. The aim was to study the prevalence and associated characteristics of AVC in a middle-aged general population.
Methods: Data were obtained from the Swedish CArdioPulmonary bioImage Study (SCAPIS) comprising 30,154 individuals 50 to 64 years from the general population recruited in Sweden between 2013-2018. AVC was assessed visually on computed tomography (CT) and categorized as evident or not. Population attributable risk proportion (PARP) was calculated for six modifiable risk factors (smoking, hypertension, hyperlipidemia, diabetes, BMI ≥median and kidney dysfunction [eGFR <60 ml/min/1.73 m2]).
Results: In total, 29,221 individuals with CT images available were included (mean age 57.5 years, 51% female) and AVC was present in 2,053 (7%). The AVC prevalence increased with age (50-54 years: 3%; 55-59 years: 7%; 60-64 years: 11%). In analyses adjusted for age, sex, smoking and study site, male sex (OR 2.02, 95% CI 1.84-2.22), hyperlipidemia (1.88 [1.68-2.11]), hypertension (1.73 [1.57-1.91]), diabetes (1.66 [1.39-1.97]), kidney dysfunction (1.54 [1.10-2.11]), smoking (1.36 [1.24-1.50]), age (increment by one year) (1.12 [1.11-1.13]) and BMI (increment by one unit) (1.04 [1.03-1.05) were associated with AVC. The PARP of AVC associated with the six modifiable risk factors was 34.5% (95% CI 29.6-39.4).
Conclusions: In this large, contemporary middle-aged general population, AVC was prevalent in as many as 7% and six cardiovascular risk factors contributed to one third of the prevalence of AVC.
目的:主动脉瓣钙化(AVC)是主动脉瓣狭窄的潜在病理生理机制,在老年人中很常见,但在年轻人中鲜为人知。目的是研究中年普通人群中AVC的患病率及其相关特征。方法:数据来自瑞典心肺生物图像研究(SCAPIS),该研究包括2013-2018年间在瑞典招募的30,154名50至64岁的普通人群。AVC在计算机断层扫描(CT)上进行视觉评估,并分为明显或不明显。计算了6个可改变的危险因素(吸烟、高血压、高脂血症、糖尿病、BMI≥中位数和肾功能障碍)的人群归因风险比例(PARP) [eGFR结果:总共纳入了29,221例可获得CT图像的个体(平均年龄57.5岁,51%为女性),2053例(7%)存在AVC。AVC患病率随年龄增长而增加(50-54岁:3%;55-59岁:7%;60-64岁:11%)。在对年龄、性别、吸烟和研究地点进行校正的分析中,男性(OR 2.02, 95% CI 1.84-2.22)、高脂血症(1.88[1.68-2.11])、高血压(1.73[1.57-1.91])、糖尿病(1.66[1.39-1.97])、肾功能障碍(1.54[1.10-2.11])、吸烟(1.36[1.24-1.50])、年龄(增加1年)(1.12[1.11-1.13])和BMI(增加1个单位)(1.04[1.03-1.05)与AVC相关。AVC与6个可改变危险因素相关的PARP为34.5% (95% CI 29.6-39.4)。结论:在这个庞大的当代中年普通人群中,AVC患病率高达7%,6种心血管危险因素占AVC患病率的三分之一。
期刊介绍:
European Journal of Preventive Cardiology (EJPC) is an official journal of the European Society of Cardiology (ESC) and the European Association of Preventive Cardiology (EAPC). The journal covers a wide range of scientific, clinical, and public health disciplines related to cardiovascular disease prevention, risk factor management, cardiovascular rehabilitation, population science and public health, and exercise physiology. The categories covered by the journal include classical risk factors and treatment, lifestyle risk factors, non-modifiable cardiovascular risk factors, cardiovascular conditions, concomitant pathological conditions, sport cardiology, diagnostic tests, care settings, epidemiology, pharmacology and pharmacotherapy, machine learning, and artificial intelligence.